Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Arterial diseases of the limbs

Arterial diseases of the limbs affect the arteries supplying blood to the arms and legs and may compromise movement, sensation and tissue viability. They include narrowing and occlusion, but also arterial wall lesions capable of producing emboli, dilatation or compression. Their clinical presentation reflects the interaction of three factors: the disease mechanism, the anatomical site and the time available for the circulation to adapt. A slowly progressive stenosis may be compensated for years, whereas sudden obstruction of the same segment can rapidly threaten a previously healthy limb.

Lower-extremity arterial disease in adults is predominantly atherosclerotic and is an important cause of walking limitation and foot lesions. In upper-extremity arterial diseases, embolism, subclavian disorders, trauma, compression and disturbances of digital circulation have relatively greater importance. This difference precludes automatically applying to the hand diagnostic criteria, classifications or treatments developed for the leg. The lower frequency of upper-limb loss does not diminish the importance of damage that can impair grip, precision and personal independence.

Atherosclerotic forms become more common with age and exposure to tobacco, diabetes, dyslipidemia and kidney disease. Epidemiological data on lower-extremity PAD, however, do not describe all these conditions: an athlete with popliteal compression, a person with brachial embolism and a patient with autoimmune digital ischemia belong to different populations. In each case, the diagnosis must specify both cause and presentation, rather than merely applying the label of arterial insufficiency. Prognostic implications also differ: atherosclerosis signals systemic cardiovascular risk, whereas an isolated traumatic lesion mainly raises local and functional concerns.

Etiology, pathogenesis and pathophysiology

In atherosclerosis, the arterial wall retains atherogenic lipoproteins and develops an inflammatory and reparative response that progressively alters the intima and lumen. Plaque contains varying proportions of lipids, cells, fibrous tissue and calcium; thrombosis may accompany lesion growth and turn stenosis into occlusion. Smoking promotes endothelial injury and thrombogenicity, diabetes disrupts vascular metabolism and tissue repair, while kidney failure also contributes to calcific arterial stiffness. Disease distribution and microcirculatory quality explain why two people with apparently similar narrowing may have very different manifestations.

Embolism, by contrast, introduces material from a distant source into the limb circulation. A cardiac thrombus may lodge at a bifurcation and interrupt flow before the distal artery has had time to develop compensatory pathways. Plaques and aneurysms can release thrombotic or atheromatous material into smaller vessels. In blue toe syndrome, distal arterial compromise may coexist with palpable foot pulses: a detectable pulse describes the artery being examined and does not guarantee the integrity of the entire downstream vascular network. Identifying the source is essential to prevent further embolization.

Trauma, endovascular procedures and anatomical compression may cause intimal injury, dissection, thrombosis or pseudoaneurysms. Injury does not always cause immediate occlusion: repeatedly deformed arterial walls may later become sites of thrombus formation and embolization. Popliteal artery entrapment syndrome and compression of the subclavian artery in the thoracic outlet illustrate how the relationship between an artery and musculoskeletal structures may be the primary problem. In aneurysms, by contrast, altered flow within the dilatation promotes mural thrombus and distal complications even without rupture.

Inflammatory and functional causes require a different approach. Vasculitis may affect the wall and lumen of arteries of various sizes; thromboangiitis obliterans causes segmental obstruction closely associated with tobacco use. Raynaud phenomenon mainly involves episodes of digital vasoconstriction, which in secondary forms can overlap with structural injury. A hemodialysis fistula introduces another possibility: some blood flow is diverted into a low-resistance circuit and hand perfusion may become inadequate, particularly when arterial inflow or compensatory capacity is already impaired. The resulting ischemia may be similar, but effective treatment depends on recognizing the mechanism.

Stenosis primarily limits the rise in flow needed during activity. When muscles and arterioles have already used much of their vasodilatory capacity, exertion creates a mismatch between oxygen demand and supply. This produces claudication, in the leg when walking or in the arm during repeated activity. Collateral connections can limit the deficit, but their effectiveness depends on the time available for development, available pressure and additional obstructions. In the lower limb, circulation must also sustain distal tissues frequently exposed to pressure, friction and minor trauma; in the hand, the integrity of the palmar arches determines the ability to compensate for loss of one of the forearm arteries.

Chronic ischemic injury affects muscle, nerves and healing capacity. Metabolic disturbances, reduced activity and deconditioning may amplify functional impairment beyond what vascular imaging suggests. If perfusion becomes inadequate even at rest, the tissue no longer has the reserve needed to repair a wound and resist infection. In acute occlusion, by contrast, an energy deficit can rapidly lead to loss of nerve function and muscle necrosis. Subsequent reperfusion does not automatically reverse established injury and may add edema and systemic metabolic disturbances.

Clinical manifestations: history and physical examination

The history must first establish the timeline. A symptom reproducible at the same workload suggests reduced flow reserve; a sudden change in pain, temperature or sensation suggests a new occlusion. The triggering activity, location, duration and manner of resolution must be clarified. Walking distance is meaningful only alongside speed, gradient and coexisting limitations; for the upper limb, questions about manual work, overhead activity, fatigue and loss of dexterity are useful. Absence of pain during activities that have already been substantially curtailed can conceal significant disease.

Rest pain, particularly when distal and associated with wounds or necrosis, requires assessment of tissue perfusion. In a severely ischemic foot, a dependent position may ease nocturnal pain; in the hand, finger pain, cold intolerance and difficulty with fine movements may predominate. Neuropathy, diabetes and analgesic treatments may alter presentation. Previous transient episodes, vascular procedures, arterial access, dialysis fistulas, atrial fibrillation and repeated trauma should also be investigated. A painful digital lesion must not be attributed to a vague circulation problem before its origin has been established.

In acute limb ischemia, pain, pallor, absent pulses, coldness, paresthesia and motor impairment may occur. Not all signs are present from the beginning, and their complete combination is not a prerequisite for action. Loss of sensation and especially weakness indicate a major threat. A patient with pre-existing neuropathy may require even closer assessment of changes from their usual condition. Onset time guides management, but tissue viability is established through clinical examination and vascular findings.

The physical examination compares both sides and follows the arterial course from the limb root to its extremities. Color, temperature, trophic changes, wounds and their distribution are assessed, followed by examination of proximal and distal pulses, supplemented with Doppler when needed. Auscultation looks for bruits in accessible segments without equating their intensity with stenosis severity. In the legs, the sole, heel and interdigital spaces must be examined; in the hands, every finger and the palmar surface. Sensation, movement, deformities and signs of infection complete the assessment, because arterial reconstruction is valuable when it preserves tissue and function.

Comparing blood pressure between the arms may suggest a proximal lesion, but a single discrepant reading should be repeated correctly. Bilateral disease may lower pressure in both arms, making asymmetry less apparent. With subclavian lesions, symptoms related to arm exertion and a history of coronary bypass using the internal thoracic artery should be sought. Episodic, symmetric, cold-induced color changes point to a different process from persistent ischemia affecting one finger. Positional maneuvers may contribute to evaluating compression, but transient pulse loss alone does not establish an arterial syndrome.

Investigations, diagnosis and disease characterization

The diagnostic pathway must demonstrate impaired perfusion, localize it and attribute it to a plausible cause. In chronic lower-limb disease, the ankle–brachial index is often the starting point: a correctly measured value no higher than 0.90 is abnormal. Stiff, noncompressible arteries, common in diabetes and kidney disease, require interpretation using toe pressures and waveforms. When exertion causes symptoms but resting results are normal or borderline, post-exercise testing may reveal the deficit. These thresholds apply to lower-limb assessment and are not universal criteria for every vascular territory.

Measures of local perfusion are especially useful when wounds or rest pain are present. Toe pressures, photoplethysmography, transcutaneous oximetry and other methods provide information complementary to the patency of large arteries. Temperature, edema, infection and acquisition technique may affect the results. A diagnosis of chronic limb-threatening ischemia requires integrating arterial disease with persistent clinical manifestations, rather than reducing a complex condition to a single pressure threshold. In the hand, specific distal assessments are used according to suspicion of large-artery disease, embolism or digital vasculopathy.

Duplex ultrasonography helps establish lesion location, flow direction and hemodynamic consequences. Focal acceleration, altered post-stenotic flow or absence of a signal must be interpreted together with morphology and technical conditions. The examination can also assess aneurysms, pseudoaneurysms and previous reconstructions. When compression is suspected, dynamic imaging must document the relationship between position, lesion and symptoms; with a dialysis fistula, access flow and possible obstacles to hand inflow are also relevant.

Anatomical imaging with CT angiography or MR angiography is selected when a broader vascular map or treatment planning is needed. CT is rapid and depicts the arterial wall, lumen and surrounding structures well, although calcification and artifacts can limit precision in small vessels. MRI may offer advantages for selected questions, taking devices, acquisition times and protocols into account. Catheter angiography is used chiefly when detailed luminal assessment may be followed by treatment. In an immediately threatened limb, the sequence is adapted to urgency: a test useful for stable disease must not create a delay incompatible with tissue salvage.

The etiological workup follows the findings. In embolism, the heart, rhythm and proximal arterial sources are assessed; in inflammatory disease, systemic history, targeted tests and vessel wall imaging are combined; in traumatic lesions, the anatomical relationship to local injury is important. Blood count, renal function, lipid profile and glycemic assessment help characterize the patient and treatment safety. Indiscriminate extensive panels seldom clarify typical atherosclerosis, whereas a young or unusual presentation justifies selective investigation.

After confirmation, extent and severity are described, distinguishing functional capacity, tissue threat and overall risk. Clinical classifications for the legs facilitate communication; in injured feet, assessment of wound, ischemia and infection expresses risk better than walking distance alone. In the hand, sensation, strength and finger use must also be documented. The differential diagnosis includes joint disorders, neuropathies, nerve compression, venous disorders and skin lesions of other origins, which may coexist with arterial disease and explain some symptoms.

Treatment and prognosis

Treatment is organized around a clinical goal: improve restricted function, heal a lesion, stop embolization or salvage an acutely ischemic limb. The choice depends on the cause. In atherosclerotic disease, prevention includes tobacco cessation, reduction of atherogenic lipoproteins and management of blood pressure and diabetes; these measures continue even when a procedure has restored flow. In mechanical compression or vasculitis, by contrast, the underlying process must be addressed as well as its vascular consequences.

Antithrombotic agents must be matched to the disease and bleeding risk. Antiplatelet prevention in symptomatic atherosclerotic PAD, anticoagulation for a cardioembolic source and treatment after reconstruction have different indications. Aspirin combined with vascular-dose rivaroxaban is used in selected patients with atherosclerotic disease, but it is not the treatment for every form of peripheral ischemia. The duration of dual antiplatelet treatment also depends on the procedural context and comorbidities, rather than the mere presence of stenosis.

For leg claudication, structured walking, either supervised or supported by an organized home program, improves performance and reduces disability. Exercise intensity is tailored to the patient and distinguished from management of an ulcerated foot or acute symptoms. For the upper limbs, activity, ergonomics and functional recovery are adapted to the cause without assuming that protocols studied for leg claudication automatically apply. Treating pain and associated limitations facilitates rehabilitation, but ongoing ischemia must be addressed directly.

Revascularization, endovascular, surgical or combined, is selected with regard to anatomy, tissue to be salvaged, patient risk and expected duration of benefit. In symptomatic chronic disease, the indication depends on residual disability despite adequate treatment; in a threatened limb, the priority is perfusion sufficient for tissue survival. An embolizing aneurysm may require exclusion and reconstruction, compression requires correction of the anatomical conflict, and a dialysis fistula problem may call for flow modification. Success must also be measured in terms of healing and function.

Acute occlusions require urgent vascular evaluation. Initial anticoagulation, when appropriate and not contraindicated, limits thrombus extension while the method of reperfusion is determined. Thromboembolectomy, catheter-directed thrombolysis, thrombectomy and reconstructive techniques have selective indications; sensation and movement help determine how much time is available. Tissue protection continues after lumen restoration because compartment syndrome, metabolic injury and infection may emerge. Tissue already irreversibly necrotic may require amputation or resection within a rehabilitation plan.

Prognosis depends on the ability to control the cause and recurrences, the presence of systemic disease and residual function. Surveillance includes symptom trends, skin integrity, adherence and, when indicated, assessment of the reconstruction. Prevention of another event is paramount in embolic disease; anatomical and functional recovery in compression; and long-term cardiovascular protection in atherosclerosis. Anatomical preservation of the limb is essential, but a painful, insensate hand or an unusable leg still requires care and rehabilitation.

Complications

Disability may precede any visible lesion. Walking less or gradually giving up manual work reduces strength, endurance and social participation; deconditioning in turn makes recovery more difficult. Ischemic nerve injury may leave pain, sensory deficits and weakness even after reperfusion. In neuropathic feet and fingers with reduced sensation, repeated minor injuries may go unnoticed and prolong damage.

Impaired tissue repair promotes ulceration and gangrene. Infection may spread into deep tissues and bone, progressing to sepsis; the extent of tissue damage and residual perfusion influence the possibility of salvage. Recurrent embolization can cause new areas of ischemia even after initial improvement. Aneurysms also carry risks of compression of neighboring structures and, depending on site and etiology, rupture.

After prolonged ischemia, reperfusion may cause edema, increased compartment pressure, release of potassium and myoglobin, and kidney injury. Procedures may also be complicated by restenosis, thrombosis, bleeding, embolization and infection. In atherosclerotic disease, myocardial infarction and stroke reflect risk throughout the vascular tree; successful local treatment does not eliminate this prognostic component. Managing complications therefore requires continuity between limb assessment, control of the cause and treatment of systemic conditions.

References
  1. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538-3700.
  2. Gornik HL et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(24):e1313-e1410.
  3. Criqui MH et al. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021;144(9):e171-e191.
  4. Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524-533.
  5. Hiatt WR et al. Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circulation Research. 2015;116(9):1527-1539.
  6. Aboyans V et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-2909.
  7. Conte MS et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Journal of Vascular Surgery. 2019;69(6S):3S-125S.e40.
  8. Fitridge R et al. Editor’s Choice - The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer. European Journal of Vascular and Endovascular Surgery. 2023;66(4):454-483.
  9. Maverakis E et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. Journal of Autoimmunity. 2014;48-49:60-65.
  10. Olin JW. Thromboangiitis obliterans (Buerger’s disease). The New England Journal of Medicine. 2000;343(12):864-869.
  11. Creager MA et al. Acute limb ischemia. The New England Journal of Medicine. 2012;366(23):2198-2206.
  12. Mach F et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2025;46(42):4359-4378.
  13. Friedman DD et al. CT Angiography of the Upper Extremities: Review of Acute Arterial Entities. RadioGraphics. 2025;45(1):e240077.
  14. Aitken E et al. UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis. BMC Nephrology. 2025;26(1):461.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.